IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Boxer Capital, LLC

Q1 2017 Holdings

Filed 2017-05-15 | 31 holdings | $45.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beigene LTD(ONC)SPONSORED ADR07725L102$31.1M850,00067.9%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$12.8M250,00028.0%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.5M291,2303.2%
Avexis IncCOM05366U100$78.2K1,028,7630.2%
Clovis Oncology Inc(CLVSEUR)COM189464100$63.7K1,000,0000.1%
Medicines CompanyCOM584688105$59.4K1,215,0000.1%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$45.0K1,275,0000.1%
Medicines CompanyCallCALL584688905$33.4K683,7000.1%
Blueprint Medicines Corp(2L9)COM09627Y109$30.8K770,1590.1%
PTC Therapeutics Inc(PTCT)COM69366J200$14.8K1,500,0000.0%
Aquinox Pharmaceuticals IncCOM03842B101$14.7K877,7530.0%
Incyte Corp(INCY)COM45337C102$13.4K100,0000.0%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$9.1K75,0000.0%
Seattle Genetics IncCOM812578102$6.3K100,0000.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$5.4K1,037,9940.0%
LA Jolla Pharmaceutical Co(LJPC)COM PAR $.0001 2503459604$5.0K167,4000.0%
Kura Oncology Inc(KURA)COM50127T109$4.7K533,2510.0%
Strongbridge Biopharma PLCSHS USDG85347105$4.5K940,0000.0%
Puma Biotechnology Inc(PBYI)COM74587V107$3.7K100,0000.0%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$3.3K777,2020.0%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$3.2K234,2200.0%
Bellerophon Therapeutics Inc(BLPHEUR)COM078771102$2.8K1,857,1430.0%
Sunesis Pharmaceuticals IncCOM PAR867328700$2.2K525,0000.0%
Nabriva Therapeutics AGSPONSORED ADR62957M104$2.1K176,7100.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$1.6K138,3310.0%
Anaptysbio Inc(ANAB)COM032724106$1.4K50,0000.0%
Akari Therapeutics PLCSPONSORED ADR00972G108$1.1K95,0110.0%
Onconova Therapeutics IncCOM NEW68232V306$962316,3860.0%
Aradigm Corp(ARDMEUR)COM NO PAR NEW038505400$893576,2080.0%
Nexvet Biopharma PUB LTD CoORD SHSG6503X109$602154,8400.0%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$202241,6440.0%